Jennifer Lafleur
Family · Lincoln, RINPI 1730314287
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Alkermes, Inc. at 24.6% of the total. Among family clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $23.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$847
- Otsuka America Pharmaceutical, Inc.$720
- AbbVie$507
- Axsome Therapeutics, Inc.$290
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$283
- Neurocrine Biosciences, Inc.$180
- plus $611 from 9 others
What the payments were for
- Food & beverage$3,439100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 33 | $847 |
| Otsuka America Pharmaceutical, Inc. | 31 | $720 |
| AbbVie | 22 | $507 |
| Axsome Therapeutics, Inc. | 9 | $290 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $283 |
| Neurocrine Biosciences, Inc. | 9 | $180 |
| Teva Pharmaceuticals USA, Inc. | 7 | $150 |
| Corium, LLC | 5 | $120 |
| Johnson & Johnson | 6 | $113 |
| Lundbeck LLC | 3 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Abiomed | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$480
- ARISTADA$400
- Auvelity$125
- ARISTADA INITIO$100
How this compares
$3,439 in reported general payments places this provider in the 90th percentile of 457 family providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 27 | $230 |
| Gabapentin | 13 | $191 |
| Lamotrigine | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other family in Lincoln
- Shrenik VyasLincoln$11K
- Carol RobinsonWarwick$82K
- Mark ClarkeSmithfield$37K
- Olga FedorenkoCoventry$24K
- Alicia VatterWarwick$15K
- Kaleigh RapozaJohnston$14K
- David RamosRiverside$14K
- Sharon BensonNorth Smithfield$12K
- Michelle Blade MelloWest Warwick$12K
- Hollie ColucciWest Warwick$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.